Portal:PancCanNet

From WikiPathways

The PanCanNet Portal on WikiPathways

Welcome to the PancCanNet Pathway Portal

This portal highlights pathway content relevant to the pancreatic cancer research community.

The aim of this project is the creation of a biological pathway community portal (PancCanNet) as a unified knowledge base for pancreatic cancer. The portal enables expert clinical researchers (medical and scientific) to add and curate pathway content and allows programmatic access for downstream knowledge integration, data analysis, and data visualization. PancCanNet provides a resource for determining the functional impact of multi-omics experimental data with the aim to understand the mechanisms of treatment resistance, discover novel biomarkers and develop personal treatment options for pancreatic cancer patients.

edit

Pathway Curation

To the right you'll see a rotating display of featured pathways related to pancreatic cancer. Where did these pathways come from? They came from people like you! The pancreatic cancer collection of pathways can be edited, fixed, and added to using the pathway drawing and annotation tools here at WikiPathways.

Getting Started

Introduction to WikiPathways (slides)
WikiPathways Overview or New Contributor Quickstart
General help pages

Resources

PancCanNet project [add link]
Pathway analysis
- Cytoscape and the WikiPathways app
- PathVisio and the WikiPathways plugin

Curation projects

Contact Martina Kutmon if interested in curating, adding, or using pancreatic cancer pathways, [email protected]

edit

Useful Links

More information about the PancCanNet project: https://panccannet.github.io/
Workshop about analysis workflows: https://panccannet.github.io/workshop/

edit

Featured Pathways

G1 to S cell cycle control (Homo sapiens)

G1 to S cell cycle control

View all Pathways for this Portal

edit

Support

The PancCanNet project has received funding from The Netherlands Organization for Health Research and Development under the ZonMw Hotel project number 435005037.